Learn more about Abbott's line of Freestyle Libre continuous glucose monitors (CGMs).
Medtronic
+4
/
Dec 2, 2025
Medtronic's latest CGM built by Abbott, the Instinct, brings 15-day wear and a smaller design to MiniMed 780G users in the U.S.
News
+2
Abbott recalls 3 million Libre 3 CGMs after detecting potential low glucose reading errors, impacting user safety, with 736 reported adverse events and seven deaths.
CGM
+3
Oct 22, 2025
Tandem Diabetes Care confirms upcoming compatibility between the t:slim X2 insulin pump and the FreeStyle Libre 3 Plus sensor this year.
+5
Oct 17, 2025
We tried the Libre 3 Plus continuous glucose monitor for a month and dive into its features, smartphone app, alerts, accuracy and more.
Dexcom
+6
Sep 10, 2025
The top continuous glucose monitors are set to get new features. From longer wear times, to multiple measured analytes, here’s what’s next in CGM innovation.
Sep 2, 2025
Medtronic's SmartGuard algorithm is cleared for the upcoming 15-day Instinct CGM and the MiniMed 780G gets clearance for type 2 diabetes.
Aug 11, 2025
Medtronic's new CGM built by Abbott is 510(k) pending and under FDA review, signaling major changes ahead for MiniMed insulin pumps.
Jul 8, 2025
From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out.
Jun 20, 2025
Abbott’s flagship CGM now powers Tandem’s Control-IQ+ system—with more pump integrations and a ketone sensor on the horizon.
+7
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
Jun 12, 2025
The next wave of continuous glucose monitors promises better accuracy, longer wear time and more insulin pump integrations.
Apr 21, 2025
Abbott's new app brings much needed upgrades like silence Low Alarms and control of all sensors under one umbrella.
Aug 17, 2024
A new Abbott sensor is coming to Medtronic’s 780G--here's what we expect from the upcoming device.
